---
title: "Benzoic acid - Hyperammonemia"
sidebar: mydoc_sidebar
permalink: db03793-mesh-d022124-1.html
toc: false 
---


Path ID: `DB03793_MESH_D022124_1`
{% include image.html url="images/db03793-mesh-d022124-1.png" file="db03793-mesh-d022124-1.png" alt="db03793-mesh-d022124-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D019817 | Benzoic acid | Drug |
| MESH:D005998 | Glycine | ChemicalSubstance |
| GO:0007588 | Renal excretion | BiologicalProcess |
| MESH:D000641 | Ammonia | ChemicalSubstance |
| MESH:D022124 | Hyperammonemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Benzoic Acid | MOLECULARLY INTERACTS WITH | Glycine |
| Glycine | POSITIVELY REGULATES | Renal Excretion |
| Renal Excretion | DECREASES ABUNDANCE OF | Ammonia |
| Ammonia | CONTRIBUTES TO | Hyperammonemia |
|---------|-----------|---------|

Comment: Benzoic acid is used in the salt form sodium benzoate

Reference: 
  - [https://go.drugbank.com/drugs/DB03793#mechanismofaction](https://go.drugbank.com/drugs/DB03793#mechanismofaction)
  - [https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020645lbl.pdf](https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020645lbl.pdf)
  - 
  - [https://en.wikipedia.org/wiki/Hyperammonemia#Treatment](https://en.wikipedia.org/wiki/Hyperammonemia#Treatment)

Reference: 
  - [https://go.drugbank.com/drugs/DB03793#mechanismofaction](https://go.drugbank.com/drugs/DB03793#mechanismofaction)
  - [https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020645lbl.pdf](https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020645lbl.pdf)
  - 
  - [https://en.wikipedia.org/wiki/Hyperammonemia#Treatment](https://en.wikipedia.org/wiki/Hyperammonemia#Treatment)

Reference: 
  - [https://go.drugbank.com/drugs/DB03793#mechanismofaction](https://go.drugbank.com/drugs/DB03793#mechanismofaction)
  - [https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020645lbl.pdf](https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020645lbl.pdf)
  - 
  - [https://en.wikipedia.org/wiki/Hyperammonemia#Treatment](https://en.wikipedia.org/wiki/Hyperammonemia#Treatment)

Reference: 
  - [https://go.drugbank.com/drugs/DB03793#mechanismofaction](https://go.drugbank.com/drugs/DB03793#mechanismofaction)
  - [https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020645lbl.pdf](https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020645lbl.pdf)
  - 
  - [https://en.wikipedia.org/wiki/Hyperammonemia#Treatment](https://en.wikipedia.org/wiki/Hyperammonemia#Treatment)
